SCHEMBL28464572

SCHEMBL28464572

CCOC(=O)COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1C(N)=O

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AXL P30530 18/20 0.76
MET P08581 12/20 0.73
MERTK Q12866 7/20 0.73
AURKA O14965 1/20 0.68
RIPK2 O43353 1/20 0.68
ABCB11 O95342 1/20 0.68
ABL1 P00519 1/20 0.68
EGFR P00533 1/20 0.68
ERBB2 P04626 1/20 0.68
NTRK1 P04629 1/20 0.68
LCK P06239 1/20 0.68
PGR P06401 1/20 0.68
LYN P07948 1/20 0.68
RET P07949 1/20 0.68
CHRM2 P08172 1/20 0.68
HCK P08631 1/20 0.68
ADRA2A P08913 1/20 0.68
ADORA3 P0DMS8 1/20 0.68
KIT P10721 1/20 0.68
CHRM1 P11229 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30152524 0.88 AXL (0.95) AXLMETMERTKAURKARIPK2
SCHEMBL21201164 0.88 AXL (0.95) AXLMETMERTKAURKARIPK2
SCHEMBL21200838 0.86 AXL (0.85) AXLMETMERTKAURKARIPK2
SCHEMBL21201043 0.86 AXL (1.00) AXLMETMERTKAURKARIPK2
SCHEMBL30152514 0.86 AXL (1.00) AXLMETMERTKAURKARIPK2
SCHEMBL21200460 0.86 AXL (0.84) AXLMETMERTKAURKARIPK2
SCHEMBL30152465 0.86 AXL (0.84) AXLMETMERTKAURKARIPK2
SCHEMBL21200891 0.86 AXL (0.84) AXLMETMERTKAURKARIPK2
SCHEMBL21200906 0.85 AXL (0.78) AXLMETMERTKAURKARIPK2
SCHEMBL30152521 0.85 AXL (0.78) AXLMETMERTKAURKARIPK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117820226-A Compounds for the treatment of kinase dependent disorders 埃克塞里艾克西斯公司 2024-04-05 CN disclosed
CN-117624045-A Compounds for the treatment of kinase dependent disorders 埃克塞里艾克西斯公司 2024-03-01 CN disclosed
CN-117603138-A Compounds for the treatment of kinase dependent disorders 埃克塞里艾克西斯公司 2024-02-27 CN disclosed
CN-111757735-B Compounds for the treatment of kinase dependent disorders 埃克塞里艾克西斯公司 2023-09-22 CN disclosed
CN-111757735-A Compounds for the treatment of kinase-dependent disorders 埃克塞里艾克西斯公司 2020-10-09 CN disclosed